Thursday, October 23, 2008
Changing the rules about setting a clot-preventing medicine made a difference in the lives of heart patients, a new Canadian study finds. When the Ontario health insurance system made it simpler for doctors to lay down Plavix to people who stents had entrenched after artery-opening processes, the number of deaths, heart attacks and following cardiac procedures had cut down considerably, according to a report in the Oct. 23 issue of the New England Journal of Medicine.
"We anticipated that there would be a reduced delay in receiving the medication when a less restrictive policy was adopted," said study author Cynthia A. Jackevicius, an associate professor of pharmacy at the Western University of Health Sciences in California. "It also changed the medical outcomes."
"We anticipated that there would be a reduced delay in receiving the medication when a less restrictive policy was adopted," said study author Cynthia A. Jackevicius, an associate professor of pharmacy at the Western University of Health Sciences in California. "It also changed the medical outcomes."

0 Comments:
Post a Comment
<< Home